---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-037389"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:37:48.210763+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Aytu BioPharma stockholders elect all director nominees, ratify auditor, approve say-on-pay

## Summary
- All five incumbent directors reelected: Disbrow, Donofrio, Dockery, Jain, Liu with majority votes.
- Grant Thornton LLP ratified as independent auditor for fiscal 2026: 5,783,905 for, 257,411 against.
- Non-binding advisory vote on executive compensation approved: 3,193,511 for, 311,200 against.
- Approximately 60% of outstanding shares (6,083,713) present or represented at meeting.

## SEC filing metadata
- accession: 0001437749-25-037389
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000143774925037389/0001437749-25-037389-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000143774925037389/aytu20251204_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-037389
- JSON: https://secwatch.observer/filing/0001437749-25-037389.json
- Plain text: https://secwatch.observer/filing/0001437749-25-037389.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.